Worldwide, numbers of heart attacks and strokes will rise this decade. Blood thinners will play important roles in medicine, helping to prevent and treat cardiovascular disorders.
Visiongain's study provides data, analysis and opinion aiming to benefit your research, calculations, meetings and presentations. You will find answers in our work.
Revenue forecasts, market shares, developmental trends, discussions and interviews
In the report you find revenue forecasting, growth rates, market shares, qualitative analyses (including SWOT and STEP), opinions and R&D news. You receive 82 tables and charts and four research interviews.
Advantages of Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 for your work
In particular, this study gives you the following knowledge and benefits:
• Find revenue predictions to 2022 for the overall world market and submarkets
• Discover revenue forecasts to 2022 for 14 drugs, assessing commercial potential
• See revenue forecasts to 2022 for leading national markets - US, Japan, Germany, France, UK,Spain, Italy, China and India
• Assess leading companies, discovering activities and outlooks
• Review R&D, seeing pipeline trends
• Investigate competition and opportunities influencing sales results
• Find out what will stimulate and restrain the industry and market
• View opinions from our survey of authorities on the sector.
There, you receive a distinctive mix of quantitative and qualitative work with independent predictions. We analyse developments and prospects, helping you to stay ahead.
Gain business research, data and analysis for treatment of blood clotting disorders
Copyright©2010 PR Newswire.
All rights reserved